532 related articles for article (PubMed ID: 18938203)
21. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
Kim HA; Park JH; Yi N; Lee M
Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
[TBL] [Abstract][Full Text] [Related]
22. Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF.
Klimp AH; van der Vaart E; Lansink PO; Withoff S; de Vries EG; Scherphof GL; Wilschut J; Daemen T
Gene Ther; 2001 Feb; 8(4):300-7. PubMed ID: 11313804
[TBL] [Abstract][Full Text] [Related]
23. Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection.
Liu X; Tian P; Yu Y; Yao M; Cao X; Gu J
Cancer Gene Ther; 2002 Jan; 9(1):100-8. PubMed ID: 11916239
[TBL] [Abstract][Full Text] [Related]
24. Heparin-conjugated polyethylenimine for gene delivery.
Jeon O; Yang HS; Lee TJ; Kim BS
J Control Release; 2008 Dec; 132(3):236-42. PubMed ID: 18597881
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-inducible transgene expression in differentiated human NT2N neurons--a cell culture model for gene therapy of postischemic neuronal loss.
Cao YJ; Shibata T; Rainov NG
Gene Ther; 2001 Sep; 8(17):1357-62. PubMed ID: 11571574
[TBL] [Abstract][Full Text] [Related]
26. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model.
Chi CH; Wang YS; Lai YS; Chi KH
Anticancer Res; 2003; 23(1A):315-21. PubMed ID: 12680230
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
[TBL] [Abstract][Full Text] [Related]
29. Differential transfection efficiency rates of the GM-CSF gene into human renal cell carcinoma lines by lipofection.
Hernández A; Zöller K; Enczmann J; Ebert T; Schmitz-Draeger B; Ackermann R; Wernet P
Cancer Gene Ther; 1997; 4(1):59-65. PubMed ID: 9012452
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
[TBL] [Abstract][Full Text] [Related]
31. Polyethyleneimine-mediated gene delivery into human adipose derived stem cells.
Ahn HH; Lee JH; Kim KS; Lee JY; Kim MS; Khang G; Lee IW; Lee HB
Biomaterials; 2008 May; 29(15):2415-22. PubMed ID: 18295879
[TBL] [Abstract][Full Text] [Related]
32. Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg.
Kim JB; Choi JS; Nam K; Lee M; Park JS; Lee JK
J Control Release; 2006 Aug; 114(1):110-7. PubMed ID: 16842881
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional and post-translational regulatory system for hypoxia specific gene expression using the erythropoietin enhancer and the oxygen-dependent degradation domain.
Kim HA; Kim K; Kim SW; Lee M
J Control Release; 2007 Aug; 121(3):218-24. PubMed ID: 17628167
[TBL] [Abstract][Full Text] [Related]
34. In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells.
Zhu XP; Chen ZZ; Li CT; Lin X; Zhuang JL; Hu JD; Yang T; Xu ZS
Chin Med J (Engl); 2008 Nov; 121(21):2180-4. PubMed ID: 19080181
[TBL] [Abstract][Full Text] [Related]
35. Improved non-viral transfection of glial and adult neural stem cell lines and of primary astrocytes by combining agents with complementary modes of action.
Tinsley RB; Vesey MJ; Barati S; Rush RA; Ferguson IA
J Gene Med; 2004 Sep; 6(9):1023-32. PubMed ID: 15352075
[TBL] [Abstract][Full Text] [Related]
36. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.
Huang D; Desbois A; Hou ST
Gene Ther; 2005 Sep; 12(18):1369-76. PubMed ID: 15843806
[TBL] [Abstract][Full Text] [Related]
37. Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy.
Parkinson RJ; Mian S; Bishop MC; Gray T; Li G; McArdle SE; Ali S; Rees RC
Prostate; 2003 Jun; 56(1):65-73. PubMed ID: 12746848
[TBL] [Abstract][Full Text] [Related]
38. Novel constructs of tuberculosis gene vaccine and its immune effect on mice.
Dou J; Chen JS; Wang J; Chen GB; Zhao FS; Tang Q; Fang XS; Chu LL; Pan M
Cell Mol Immunol; 2005 Feb; 2(1):57-62. PubMed ID: 16212912
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effect of chondroitin sulfate-coated ternary granulocyte macrophage-colony-stimulating factor plasmid complex for ovarian cancer.
Hamada K; Yoshihara C; Ito T; Tani K; Tagawa M; Sakuragawa N; Itoh H; Koyama Y
J Gene Med; 2012 Feb; 14(2):120-7. PubMed ID: 22228506
[TBL] [Abstract][Full Text] [Related]
40. DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice.
Ito T; Yoshihara C; Hamada K; Koyama Y
Biomaterials; 2010 Apr; 31(10):2912-8. PubMed ID: 20047759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
